Metro-Minnesota Community Clinical Oncology Program (MM-CCOP)

明尼苏达都会区社区临床肿瘤学计划 (MM-CCOP)

• 批准号: 9116801
• 负责人: Daniel M Anderson
• 金额: $ 258万
• 依托单位: HEALTHPARTNERS INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-08-01 至 2019-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9116801
• 关键词: Address; Affect; American Cancer Society; American College of Radiology Imaging Network; American College of Surgeons Oncology Group; Area; Award; Awareness; Cancer Center; Cancer Control; Cancer Information Service; Cancer Patient; Cancer Research Project; Cancer and Leukemia Group B; Caring; Chemoprevention; Clinical Oncology; Clinical Research; Clinical Trials; Clinical Trials Support Unit; Clinics and Hospitals; Collaborations; Communication; Communities; Community Clinical Oncology Program; Community Hospitals; Comprehensive Cancer Center of Wake Forest University; Controlled Study; Data; Data Collection; Decision Making; Development; Doctor of Medicine; Eastern Cooperative Oncology Group; Enrollment; Environment; Evaluation; Funding; Goals; Grant; Growth; Gynecologic Oncology; Gynecologic Oncology Group; Health; Health Care Reform; Health Planning; Health Planning Councils; Health Professional; Hematology; Hospital Administration; Hospitals; Improve Access; Institutes; Institution; Institutional Review Boards; Knowledge; Link; Malignant Neoplasms; Marketing; Medical; Minnesota; Minority Participation; Modeling; Molecular Target; National Cancer Institute; National Surgical Adjuvant Breast and Bowel Project; Natural History; North Central Cancer Treatment Group; Nursing Societies; Oncologic Nursing; Oncologist; Oncology Nurse; Operations Research; Outcome; Pamphlets; Participant; Patient Recruitments; Patients; Patterns of Care; Physicians; Primary Care Physician; Protocols documentation; Quality of life; Radiation Oncology; Radiation Therapy Oncology Group; Recording of previous events; Reporting; Research; Research Infrastructure; Research Personnel; Resources; Screening for cancer; Specialist; Surgical Oncology; System; Thoracic Surgical Procedures; Time; Toxic effect; Treatment-related toxicity; Underrepresented Populations; Underserved Population; Universities; Wisconsin; anticancer research; base; cancer care; cancer clinical trial; cancer prevention; cancer therapy; care delivery; data management; follow-up; improved; meetings; member; metropolitan; novel therapeutics; oncology program; organizational structure; programs; protocol development; racial and ethnic; research and development; research study; service utilization; success; symptom management; symptom treatment; targeted agent; underserved minority; web site

DESCRIPTION (provided by applicant): The Metro-Minnesota Community Clinical Oncology (MMCCOP) program has a long-standing history which clearly demonstrates the success of the consortium, as demonstrated by both the ongoing commitment of the original consortium members and the growth of the consortium from 1979 through 2014. The MMCCOP consortium represents an established community program base which began in 1979 through its NCI-funded Community Hospital Cancer Program (CHCP) Award. This same consortium applied for and received the initial Community Clinical Oncology Program (CCOP) grant from the NCI in 1983, and has received subsequent CCOP grants since that time. In 2010, hospital, clinics and oncologists in the MN CGOP program joined the MMCOP resulting in a metrowide community cancer research program. Currently, the MMCCOP consortium represents twenty-one hospital and clinics throughout the metropolitan and greater Minnesota area, with a common approach and established mechanisms for identifying, enrolling and following participants on NC-sponsored treatment, cancer prevention, cancer control and symptom management protocols. The health market in the MMCCCP community remains extremely competitive and is in constant change as a result of mergers and Minnesota's healthcare reform initiatives. Despite this changing environment, the MMCCOP hospitals and associated staff continue to collaborate and support the added time and expense involved in clinical research trials. Their level of support has increased during a time when many other projects within the hospitals are being reduced or eliminated. This program incorporates a substantial segment of the oncology community, and has provided a basis for communications between the practicing oncologists, their hospital administrations, and other health professionals in this consortium for the past thiry years. Combined, the consortium members see an average of over 15,000 new analytic cancer patients per year. Currently, there are 146 Investigators, representing medical, hematology, radiation and surgical oncology including thoracic surgery and gynecologic oncology. The history of MMCCOP Research Base Affiliations and proactive approach to expanding access to NCI sponsored studies supports the ability to achieve and maintain the NCI goals for this NCORP initiative. MMCCOP intends to sustain a region wide community consortium which provides the community with the most recent advances in cancer prevention, treatment, symptom management and care delivery. This will be accomplished through continued affiliations with ALL1ANCE,CTSU, ECOG-ACRIN, NRG, MD Anderson, URCC and CCCWFU, the expansion of the current MMCCOP data management and communication system to increase the number and level of participation of the investigators in accrual, program operations and research base activities, implementation of new strategies to improve access and participation of underrepresented and underserved groups, and increase the professional and lay community awareness of the benefits of cancer research and collaboration with the MMCCOP to achieve the goals of the NCORP. A new focus will be to further develop and utilize expertise and data within the consortium and community to provide data and conduct cancer care delivery research. All member institutions are members of the Institutional Review Board for the Community Oncology Programs, administered by Park Nicollet Institute, which provides an efficient and timely review of studies. Over the past 5 years an average of 250 patients and 400 patients were accrued to NCI-approved treatment studies and cancer control studies respectively. Additionally, there are 1666 participants in active follow-up or surveillanc. MMCCCOP has demonstrated the ability to enter an increasing number of patients on protocol each year and proposes to accrue a total of 260 credits to Treatment studies and 400 to Cancer Control and Cancer Care Delivery research studies in the first year of this award with the goal of increasing cancer care delivery research enrollments over the next 5 year. This is a well tuned research consortium with the ability to be fully operational on day one of the award.

描述（由申请人提供）：明尼苏达都会区社区临床肿瘤学 (MMCCOP) 计划有着悠久的历史，清楚地证明了该联盟的成功，原联盟成员的持续承诺和联盟成员的发展就证明了这一点。从 1979 年到 2014 年，MMCCOP 联盟代表了一个已建立的社区计划基础，该基础于 1979 年通过 NCI 资助的社区医院癌症计划 (CHCP) 奖开始。该联盟于 1983 年向 NCI 申请并获得了最初的社区临床肿瘤学计划 (CCOP) 拨款，此后又获得了后续的 CCOP 拨款。 2010 年，明尼苏达州 CGOP 计划中的医院、诊所和肿瘤科医生加入了 MMCOP，从而形成了全市范围的社区癌症研究计划。目前，MMCCOP 联盟代表了整个大都市和大明尼苏达地区的 21 家医院和诊所，采用共同的方法和既定机制来识别、招募和跟踪 NC 资助的治疗、癌症预防、癌症控制和症状管理方案的参与者。 MMCCCP 社区的医疗市场仍然竞争激烈，并且由于合并和明尼苏达州的医疗改革举措而不断变化。尽管环境不断变化，MMCCOP 医院和相关工作人员仍继续合作并支持临床研究试验所涉及的额外时间和费用。当医院内的许多其他项目被减少或取消时，他们的支持水平有所增加。该计划涵盖了肿瘤学界的很大一部分，并为过去三十年来该联盟中的执业肿瘤学家、医院管理人员和其他卫生专业人员之间的沟通提供了基础。该联盟成员每年平均接待超过 15,000 名新的分析癌症患者。目前，共有 146 名研究者，分别来自医学、血液学、放射学和外科肿瘤学，包括胸外科和妇科肿瘤学。 MMCCOP 研究基地附属机构的历史和扩大 NCI 资助研究的积极主动方法支持实现和维持 NCI 此项 NCORP 计划目标的能力。 MMCCOP 旨在维持一个区域范围的社区联盟，为社区提供癌症预防、治疗、症状管理和护理服务方面的最新进展。这将通过继续与 ALL1ANCE、CTSU、ECOG-ACRIN、NRG、MD 安德森、URCC 和 CCCWFU 保持联系、扩展当前 MMCCOP 数据管理和通信系统以增加研究者参与权责发生制的数量和水平来实现，计划运营和研究基础活动，实施新战略以改善代表性不足和服务不足群体的获取和参与，并提高专业人士和非专业社区对癌症研究益处的认识以及与MMCCOP 实现 NCORP 的目标。新的重点将是进一步开发和利用联盟和社区内的专业知识和数据，以提供数据并进行癌症护理研究。所有成员机构都是社区肿瘤学计划机构审查委员会的成员，该委员会由 Park Nicollet 研究所管理，负责对研究进行高效、及时的审查。在过去 5 年里，平均分别有 250 名患者和 400 名患者参加了 NCI 批准的治疗研究和癌症控制研究。此外，还有 1666 名参与者正在积极跟进或监测。 MMCCCOP 已证明有能力每年让越来越多的患者参加协议，并建议在该奖项的第一年为治疗研究累计 260 个学分，为癌症控制和癌症护理提供研究累计 400 个学分，目标是未来 5 年增加癌症护理研究的注册人数。这是一个精心调整的研究联盟，有能力在获奖的第一天就全面运作。